Skip to main content

Table 2 Predictors of Viral Hepatitis

From: Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study

 

HBsAg /anti-HCV positive

Crude Odd Ratio(95%CI)

P value

Adjusted Odds Ratio (95% CI)

P value

Age > 35

2.3(0.6–8.8)

0.001

4.5(1.2–16.9)

0.02

Address

 Kirumba

4.3 (1.5–11.9)

0.006

5.1(1.7–15.3)

0.004

 Sahara

0.7(0.1–5.4)

0.70

α

 

 Bugarika

2.5(0.5–11.9)

0.27

α

 

 Igogo

1.1(0.1–9.4)

0.89

α

 

Married (compared to single)

1.7(0.6–4.8)

0.29

α

 

Low education level

10.4(0.1–2.8)

0.33

α

 

Having multiple sexual partners

1.8(0.6–5.8)

0.32

α

 

Using drugs> 9 years

3.8(1.2–12.0)

0.03

2.1(0.5–8.6)

0.29

Use of multiple drugs

1.2(0.3–5.0)

0.78

α

 

Route of drug use, injection

3.5(1.1–10.9)

0.02

3.2(0.9–10.8)

0.06

  1. Key: CI Confidence interval
  2. α Not included in multivariate analysis